Literature DB >> 9398298

Three-dimensional solution structure of alpha-conotoxin MII, an alpha3beta2 neuronal nicotinic acetylcholine receptor-targeted ligand.

K J Shon1, S C Koerber, J E Rivier, B M Olivera, J M McIntosh.   

Abstract

alpha-Conotoxin MII, isolated from Conus magus, is a potent peptidic toxin which specifically targets the mammalian neuronal nicotinic acetylcholine receptor, alpha3beta2 subtype. The three-dimensional structure of alpha-conotoxin MII in aqueous solution has been determined by two-dimensional 1H NMR spectroscopy. NOE-derived distances, refined by an iterative relaxation matrix approach, as well as dihedral and chirality restraints were used in high-temperature biphasic simulated annealing calculations. Fourteen minimum energy structures out of 50 subjected to the SA simulations were chosen for evaluation; these 14 structures have a final RMS deviation of 0.76 +/- 0.31 and 1.35 +/- 0.34 A for the backbone and heavy atoms, respectively. The overall structure is unusually well-defined due to a large helical component around the two disulfide bridges. The principal backbone folding motif may be common to a subclass of alpha-conotoxins. There are two distinct surfaces on the molecule almost at right angles to one another. One entirely consists of the hydrophobic residues Gly1, Cys2, Cys3, Leu15, and Cys16. The second comprises the hydrophilic residues Glu11, His12, Ser13, and Asn14. These surfaces on the ligand could be essential for the subtype-specific recognition of the receptor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9398298     DOI: 10.1021/bi971443r

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Solution conformation of alpha-conotoxin GIC, a novel potent antagonist of alpha3beta2 nicotinic acetylcholine receptors.

Authors:  Seung-Wook Chi; Do-Hyoung Kim; Baldomero M Olivera; J Michael McIntosh; Kyou-Hoon Han
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

2.  E.E. Just Lecture, 1996. Conus venom peptides, receptor and ion channel targets, and drug design: 50 million years of neuropharmacology.

Authors:  B M Olivera
Journal:  Mol Biol Cell       Date:  1997-11       Impact factor: 4.138

Review 3.  Natural products and ion channel pharmacology.

Authors:  Russell W Teichert; Baldomero M Olivera
Journal:  Future Med Chem       Date:  2010-05       Impact factor: 3.808

4.  Engineering stable peptide toxins by means of backbone cyclization: stabilization of the alpha-conotoxin MII.

Authors:  Richard J Clark; Harald Fischer; Louise Dempster; Norelle L Daly; K Johan Rosengren; Simon T Nevin; Frederic A Meunier; David J Adams; David J Craik
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-14       Impact factor: 11.205

5.  Structural basis for alpha-conotoxin potency and selectivity.

Authors:  Matt Turner; Seth Eidemiller; Bryan Martin; Andrew Narver; Joshua Marshall; Logan Zemp; Kenneth A Cornell; J Michael McIntosh; Owen M McDougal
Journal:  Bioorg Med Chem       Date:  2009-07-09       Impact factor: 3.641

6.  pKa determination of histidine residues in α-conotoxin MII peptides by 1H NMR and constant pH molecular dynamics simulation.

Authors:  Owen M McDougal; David M Granum; Mark Swartz; Conrad Rohleder; C Mark Maupin
Journal:  J Phys Chem B       Date:  2013-02-25       Impact factor: 2.991

7.  Acetylcholine promotes binding of α-conotoxin MII at α3 β2 nicotinic acetylcholine receptors.

Authors:  Somisetti V Sambasivarao; Jessica Roberts; Vivek S Bharadwaj; Jason G Slingsby; Conrad Rohleder; Chris Mallory; James R Groome; Owen M McDougal; C Mark Maupin
Journal:  Chembiochem       Date:  2014-01-13       Impact factor: 3.164

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.